N107-0051 Screening compound: (1R,2R,9S)-11-(1H-indazol-3-ylcarbonyl)-7,11-diazatricyclo[7.3.1.0~2,7~]tridecan-6-one

N107-0051 Screening compound: (1R,2R,9S)-11-(1H-indazol-3-ylcarbonyl)-7,11-diazatricyclo[7.3.1.0~2,7~]tridecan-6-one
N107-0051 Screening compound: (1R,2R,9S)-11-(1H-indazol-3-ylcarbonyl)-7,11-diazatricyclo[7.3.1.0~2,7~]tridecan-6-one alternative view

Chemical Structure Depiction of ChemDiv screening compound N107-0051
(1R,2R,9S)-11-(1H-indazol-3-ylcarbonyl)-7,11-diazatricyclo[7.3.1.0~2,7~]tridecan-6-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

N107-0051

Molecular Formula

C19H22N4O2 (C19 H22 N4 O2)

Compound Name

(1R,2R,9S)-11-(1H-indazol-3-ylcarbonyl)-7,11-diazatricyclo[7.3.1.0~2,7~]tridecan-6-one

IUPAC name

(1R2R9R)-11-(1H-indazole-3-carbonyl)-711-diazatricyclo[7.3.1.0^{27}]tridecan-6-one

SMILES

O=C(c1n[nH]c2c1cccc2)N(C[C@@H](C1)C2)C[C@@H]1[C@@H](CCC1)N2C1=O

InChI

InChI=1S/C19H22N4O2/c24-17-7-3-6-16-13-8-12(10-23(16)17)9-22(11-13)19(25)18-14-4-1-2-5-15(14)20-21-18/h1-2,4-5,12-13,16H,3,6-11H2,(H,20,21)/t12-,13+,16+/m0/s1

InChI Key

MNQQJAFIAHJSRA-WOSRLPQWSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

338.41

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.695

Distribution Coefficient, logD

1.695

Water Solubility, LogSw

-2.19

Polar Surface Area

56.367

Acid Dissociation Constant (pKa)

14.84

Base Dissociation Constant (pKb)

-0.45

Number of Chiral Centers

3.00

Percent sp3 carbon bonding

52.63

N107-0051 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

Natural-Product-Based Library (3730 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Pool
  • Mimetics
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with N107-0051 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound N107-0051?
Check Price and Availability of N107-0051, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of N107-0051 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for N107-0051
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for N107-0051
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of N107-0051 available by request